This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Illumina to pay $34 million to extend merger deadline with PacBio to March 31

( December 18, 2019, 21:58 GMT | Official Statement) --  MLex Summary: Illumina gave notice to Pacific Biosciences today that it is exercising its right to extend the merger's end date to March 31, 2020. As a result, Illumina will make cash payments to PacBio of $6 million on or before each of January 2, 2020 and March 2, 2020, and a cash payment of $22 million on or before February 3, 2020. Statement follows in full:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login